It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Centers for Medicare & Medicaid Services (CMS) is searching for more ways to tighten its belt. Its newest cutting proposal may be shortsighted for the large numbers of elderly patients. Among other things, CMS is proposing the elimination of antidepressants and immunosuppressants next year for Medicare beneficiaries who have private Medicare Advantage and Part D prescription drug plans. The federal government expects to save $1.3 billion between 2015 and 2019, if the proposed rule passes.
Originally, CMS required all Part D plans to cover "all or substantially all" drugs within six classes: antineoplastics, anticonvulsants, antidepressants, antiretrovirals, antipsychotics and immunosuppressants. Under the new proposal, CMS will keep drugs classified as antineoplastics, anticonvulsants, antiretrovirals, although there are even proposed exceptions to that. However, CMS will no longer require Part D formularies to include drugs from the antidepressant and immunosuppressive classes. Antipsychotic drugs will remain on Part D formularies, at least through 2015.
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraines, attention-deficit hyperactivity disorder (ADHD), substance abuse and sleep disorders.
Immunosuppressive drugs or immunosuppressive agents are drugs that inhibit or prevent activity of the immune system. They are used in immunosuppressive therapy to: Prevent the rejection of transplanted organs and tissues (e.g., bone marrow, heart, kidney, liver) Treat autoimmune diseases or diseases that are most likely of autoimmune origin (e.g., rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus erythematosus, sarcoidosis, focal segmental glomerulosclerosis, Crohn's disease, Behcet's Disease, pemphigus, and ulcerative colitis). Treat some other non-autoimmune inflammatory diseases (e.g., long term allergic asthma control).
By excluding immunosuppressive drugs from the Medicare part D program, you are effectively eliminating all over 65 patients who depend on Medicare as their coverage, when they may have met all other criteria.
Lung Transplantaton Inclusion Criteria Patients may be considered for lung or heart/lung transplantation if they present with end-stage lung disease including the following conditions: No response to conventional treatment Limited life expectancy (less than two years) Severely impaired lifestyle and exercise tolerance, NYHA Class III - IV symptoms Oxygen dependence Less than 75 years of age for single lung transplants Less than 70 years of age for double lung transplants Less than 60 years of age for heart/lung transplants
Antipsychotics (also known as neuroleptics or major tranquilizers)[1] are a class of psychiatric medication primarily used to manage psychosis (including delusions, hallucinations, or disordered thought), particularly in schizophrenia and bipolar disorder, and is increasingly being used in the management of non-psychotic disorders (ATC code N05A).
The federal government expects to save $1.3 billion between 2015 and 2019, if the proposed rule passes.
"But understand that those decisions are already being made in one way or another."
BearTruth
www.mainstreet.com...
By excluding immunosuppressive drugs from the Medicare part D program, you are effectively eliminating all over 65 patients who depend on Medicare as their coverage, when they may have met all other criteria.